A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) (Q113915010)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) |
clinical trial |
Statements
A Randomised Double-blind Placebo-controlled Clinical Trial Investigating the Effect and Safety of Oral Semaglutide in Subjects With Early Alzheimer´s Disease (EVOKE Plus) (English)
0 references
18 May 2021
0 references
9 August 2024
0 references
1,840
0 references
55 year
0 references
85 year
0 references